1-7 of 7
Jae-Hoon Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study

Yvette Drew, Jae-Weon Kim, Richard T. Penson, David M. O'Malley, Christine Parkinson, Patricia Roxburgh, Ruth Plummer, Seock-Ah Im, Martina Imbimbo, Michelle Ferguson, Ora Rosengarten, Neeltje Steeghs, Min Hwan Kim, Einav Gal-Yam, Daliah Tsoref, Jae-Hoon Kim, Benoit You, Maja De Jonge, Roy Lalisang, Eelke Gort, Sara Bastian, Kassondra Meyer, Laura Feeney, Nigel Baker, Mei-Lin Ah-See, Susan M. Domchek, Susana Banerjee, for the MEDIOLA Investigators
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (1): 50–62.
https://doi.org/10.1158/1078-0432.CCR-23-2249
Published: 05 January 2024
View articletitled, Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study
Open the PDF for Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study in another window
Includes: Supplementary data
Journal Articles

Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

Nicola S. Meagher, Kylie L. Gorringe, Matthew Wakefield, Adelyn Bolithon, Chi Nam Ignatius Pang, Derek S. Chiu, Michael S. Anglesio, Kylie-Ann Mallitt, Jennifer A. Doherty, Holly R. Harris, Joellen M. Schildkraut, Andrew Berchuck, Kara L. Cushing-Haugen, Ksenia Chezar, Angela Chou, Adeline Tan, Jennifer Alsop, Ellen Barlow, Matthias W. Beckmann, Jessica Boros, David D.L. Bowtell, for the AOCS Group, Alison H. Brand, James D. Brenton, Ian Campbell, Dane Cheasley, Joshua Cohen, Cezary Cybulski, Esther Elishaev, Ramona Erber, Rhonda Farrell, Anna Fischer, Zhuxuan Fu, Blake Gilks, Anthony J. Gill, for the Australian Pancreatic Genome Initiative, Charlie Gourley, Marcel Grube, Paul R. Harnett, Arndt Hartmann, Anusha Hettiaratchi, Claus K. Høgdall, Tomasz Huzarski, Anna Jakubowska, Mercedes Jimenez-Linan, Catherine J. Kennedy, Byoung-Gie Kim, Jae-Weon Kim, Jae-Hoon Kim, Kayla Klett, Jennifer M. Koziak, Tiffany Lai, Angela Laslavic, Jenny Lester, Yee Leung, Na Li, Winston Liauw, Belle W.X. Lim, Anna Linder, Jan Lubiński, Sakshi Mahale, Constantina Mateoiu, Simone McInerny, Janusz Menkiszak, Parham Minoo, Suzana Mittelstadt, David Morris, Sandra Orsulic, Sang-Yoon Park, Celeste Leigh Pearce, John V. Pearson, Malcolm C. Pike, Carmel M. Quinn, Ganendra Raj Mohan, Jianyu Rao, Marjorie J. Riggan, Matthias Ruebner, Stuart Salfinger, Clare L. Scott, Mitul Shah, Helen Steed, Colin J.R. Stewart, Deepak Subramanian, Soseul Sung, Katrina Tang, Paul Timpson, Robyn L. Ward, Rebekka Wiedenhoefer, Heather Thorne, for the kConFab Investigators, Paul A. Cohen, Philip Crowe, Peter A. Fasching, Jacek Gronwald, Nicholas J. Hawkins, Estrid Høgdall, David G. Huntsman, Paul A. James, Beth Y. Karlan, Linda E. Kelemen, Stefan Kommoss, Gottfried E. Konecny, Francesmary Modugno, Sue K. Park, Annette Staebler, Karin Sundfeldt, Anna H. Wu, Aline Talhouk, Paul D.P. Pharoah, Lyndal Anderson, Anna DeFazio, Martin Köbel, Michael L. Friedlander, Susan J. Ramus
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (24): 5383–5395.
https://doi.org/10.1158/1078-0432.CCR-22-1206
Published: 15 December 2022
View articletitled, Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
Open the PDF for Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes in another window
Includes: Supplementary data
Journal Articles

Abstract POSTER-BIOL-1351: Molecular characterization of cyclin-dependent kinase 1 pathway in newly established epithelial ovarian cancer cell lines

Wookyeom Yang, Hanbyoul Cho, Kim Sol, Jae-Hoon Kim
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (16_Supplement): POSTER-BIOL-1351.
https://doi.org/10.1158/1557-3265.OVCASYMP14-POSTER-BIOL-1351
Published: 15 August 2015
View articletitled, Abstract POSTER-BIOL-1351: Molecular characterization of cyclin-dependent kinase 1 pathway in newly established epithelial ovarian cancer cell lines
Journal Articles

MicroRNA Expression Profiles in Serous Ovarian Carcinoma

Eun Ji Nam, Heejei Yoon, Sang Wun Kim, Hoguen Kim, Young Tae Kim, Jae Hoon Kim, Jae Wook Kim, Sunghoon Kim
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (9): 2690–2695.
https://doi.org/10.1158/1078-0432.CCR-07-1731
Published: 01 May 2008
View articletitled, MicroRNA Expression Profiles in Serous Ovarian Carcinoma
Open the PDF for MicroRNA Expression Profiles in Serous Ovarian Carcinoma in another window
Journal Articles

Use of a Combination of Approaches to Identify and Validate Relevant Tumor-Associated Antigens and Their Corresponding Autoantibodies in Ovarian Cancer Patients

Audrey Gagnon, Jae-Hoon Kim, John O. Schorge, Bin Ye, Brian Liu, Kathleen Hasselblatt, William R. Welch, Christina A. Bandera, Samuel C. Mok
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (3): 764–771.
https://doi.org/10.1158/1078-0432.CCR-07-0856
Published: 01 February 2008
View articletitled, Use of a Combination of Approaches to Identify and Validate Relevant Tumor-Associated Antigens and Their Corresponding Autoantibodies in Ovarian Cancer Patients
Open the PDF for Use of a Combination of Approaches to Identify and Validate Relevant Tumor-Associated Antigens and Their Corresponding Autoantibodies in Ovarian Cancer Patients in another window
Journal Articles

Osteopontin as an Adjunct to CA125 in Detecting Recurrent Ovarian Cancer

John O. Schorge, Richard D. Drake, Hang Lee, Steven J. Skates, Ramababu Rajanbabu, David S. Miller, Jae-Hoon Kim, Daniel W. Cramer, Ross S. Berkowitz, Samuel C. Mok
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (10): 3474–3478.
https://doi.org/10.1158/1078-0432.CCR-03-0365
Published: 24 May 2004
View articletitled, Osteopontin as an Adjunct to CA125 in Detecting Recurrent Ovarian Cancer
Open the PDF for Osteopontin as an Adjunct to CA125 in Detecting Recurrent Ovarian Cancer in another window
Journal Articles

Identification of Epithelial Cell Adhesion Molecule Autoantibody in Patients with Ovarian Cancer

Jae-Hoon Kim, Dorothee Herlyn, Kwong-kwok Wong, Dong-Choon Park, John O. Schorge, Karen H. Lu, Steven J. Skates, Daniel W. Cramer, Ross S. Berkowitz, Samuel C. Mok
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (13): 4782–4791.
Published: 27 October 2003
View articletitled, Identification of Epithelial Cell Adhesion Molecule Autoantibody in Patients with Ovarian Cancer
Open the PDF for Identification of Epithelial Cell Adhesion Molecule Autoantibody in Patients with Ovarian Cancer in another window